Results 101 to 110 of about 30,645 (194)

Abstract Supplement HIV Glasgow 8–11 November 2026, Glasgow, UK/Virtual

open access: yes
Journal of the International AIDS Society, Volume 29, Issue S6, November 2026.
wiley   +1 more source

Serial HBV DNA levels in patients with persistently normal transaminase over 10 years following spontaneous HBeAg seroconversion

open access: yes, 2011
[[abstract]]Earlier studies addressing the hepatitis B virus (HBV) DNA cut-off level for inactive chronic HBV infection largely involved patients with normal alanine aminotransferase (ALT) for only 1–2 years and based on a single time HBV DNA assay. This
Chen, YC;Huang, SF;Chu, CM;Liaw, YF
core   +1 more source

Using machine learning models to predict HBeAg seroconversion in CHB patients receiving pegylated interferon-α monotherapy. [PDF]

open access: yesJ Clin Lab Anal, 2022
Shang H   +12 more
europepmc   +1 more source

Difference in T helper responses during hepatitis flares in hepatitis B e antigen (HBeAg)-positive patients with genotypes B and C: implication for early HBeAg seroconversion

open access: yes, 2007
The underlying mechanisms for earlier hepatitis B e antigen (HBeAg) seroconversion in patients with chronic hepatitis B virus (HBV) genotype B when compared with genotype C are unknown.
Wong, BCY   +13 more
core   +1 more source

Longitudinal changes in virological, biochemical and serological responses in subsequent months of ETV therapy in HBeAg(+) and HBeAg(-) patients at baseline.

open access: yes, 2016
Frequencies of HBV DNA
Paweł Rajewski (3185898)   +6 more
core   +1 more source

Significance of hepatitis B genotype in acute exacerbation, HBeAg seroconversion, cirrhosis-related complications, and hepatocellular carcinoma

open access: yes, 2003
The pathologic role of hepatitis B virus (HBV) genotype in Chinese patients with HBV infection is largely unknown. We examined the relationship between HBV genotypes, and hepatitis B e antigen (HBeAg) seroconversion, acute exacerbation, cirrhosis-related
Wong, BCY   +7 more
core   +1 more source

Comparison of the efficacies between LAM+ADV and LdT+ADV treatment in ALT normalization rate and DNA undetectable rate and serum HBeAg seroconversion rate.

open access: yes, 2016
Comparison of the efficacies between LAM+ADV and LdT+ADV treatment in ALT normalization rate and DNA undetectable rate and serum HBeAg seroconversion rate.
Yi-Hao Yen (837269)   +6 more
core   +1 more source

An Observational Study to Evaluate the Safety and Efficacy of Telbivudine in Adults with Chronic Hepatitis B

open access: yesActa Medica Indonesiana, 2016
Aim: to assess the safety and efficacy of telbivudine therapy in adult patients with CHB in Indonesia. Methods: the study design was prospective cohort study.
Ali Sulaiman   +3 more
doaj   +4 more sources

Development and validation of a multivariable nomogram predictive of hepatitis B e antigen seroconversion after pregnancy in hepatitis B virus-infected mothers

open access: yesFrontiers in Medicine
Background and aimsCurrent guidelines are controversial regarding the continuation of nucleos(t)ide analogues (NAs) therapy after delivery in Hepatitis B virus (HBV)-infected pregnant women.
Wenting Zhong   +6 more
doaj   +1 more source

Home - About - Disclaimer - Privacy